Duration of Dual Antiplatelet Therapy After Coronary Stenting

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|29|4583-4595

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.29, 2016-09, pp. : 4583-4595

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Three might be company for antiplatelet therapy after stenting

By  

Inpharma, Vol. 1, Iss. 1520, 2006-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Stent Thrombosis and Duration of Dual Antiplatelet Therapy

By  

Current Pharmaceutical Design, Vol. 16, Iss. 36, 2010-12 ,pp. : 4052-4063

Bentham Science Publishers

Access to resources Recommend Favorite

Optimal Duration of Antiplatelet Therapy in Recipients of Coronary Drug-Eluting Stents

By Zimarino Marco   Renda Giulia   Raffaele De Caterina  

Drugs, Vol. 65, Iss. 6, 2005-01 ,pp. : 725-732

Adis International

Access to resources Recommend Favorite

Deciphering Dual Antiplatelet Therapy in the Era of Drug-Eluting Coronary Stents

By  

Current Drug Targets, Vol. 10, Iss. 6, 2009-06 ,pp. : 519-529

Bentham Science Publishers

Access to resources Recommend Favorite

Antiplatelet therapy in acute coronary syndromes

By Menozzi Alberto   Lina Daniela   Conte Giulio   Mantovani Francesco   Ardissino Diego  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 1, 2012-01 ,pp. : 27-42

Informa Healthcare

Access to resources Recommend Favorite